StocksMedium•12 November 2026•
1 min read
Kiora Pharmaceuticals Q3 Loss Narrows Beyond Analyst Estimates
Key Facts
1Kiora Pharmaceuticals reported a GAAP EPS loss of $0.28, beating analyst estimates by $0.10.
2The company's revenue for the third quarter reached $1 million.
Kiora Pharmaceuticals reported its third-quarter financial results for 2026, posting a GAAP EPS loss of $0.28. Seeking Alpha reported that this performance beat analyst estimates by $0.10, while the company's revenue for the quarter reached $1 million.
KPRX closed at $1.35 on November 11, 2026, prior to the release of these figures. The company ended the quarter with approximately $16.3 million in cash and short-term investments, alongside $2.2 million in collaboration and tax receivables.